Proventec plc (AIM: PROV, Alternext: ALPTC), a provider of specialist steam cleaning and coatings technologies, is pleased to announce the Company's OspreyDeepclean division has won the HCAI (Healthcare Associated Infections) award from the Department of Health (DH) and NHS Purchasing and Supply Agency for the new and novel technology with the greatest contribution to enhancing the cleanliness of the hospital environment. This is the first time the DH has publically recognised the contribution Proventec's technology is making to advance healthcare environment hygiene standards and contribution to the protection of patients from healthcare associated infections.
David Chestnutt, Chief Executive of Proventec commented: "We are extremely proud to have been recognised by the DH and this award further positions Proventec Healthcare as a leader in hospital cleaning technologies. We have already seen a significant increase in enquires from UK and other international hospitals and we are actively engaged in discussion with healthcare stakeholders for the rapid deployment of the OspreyDeepclean Healthcare system."
Proventec's unique dry steam cleaning technology and specialist tooling can be used to clean and make safe all hospital surfaces in the patient environment. OspreyDeepclean Dry Steam Vapour effectively removes contamination from hospital surfaces including MRSA and Clostridium difficile. Innovative technologies, such as those developed by Proventec will be fundamental in helping the NHS achieve its goals of improving hospital cleanliness, more quickly. The successful design is the result of two years of product development and performance validation conducted by TNO laboratories, based in the Netherlands, and within UK NHS Hospital environments.
Reducing hospital infections is one of the top NHS priorities1, and a significant sum is being invested nationwide to improve standards of care though an integrated approach to infection prevention and control. Both in clinical practice and through the clean, safe hospitals HCAI Technology programme. The programme was developed to speed up the development and adoption of technologies to help further combat HCAIs, particularly MRSA and Clostridium difficile. It aims to identify which new technologies provide the best value and which will have the most impact.
The HCAI Technology Innovations awards were launched for the first time this year to highlight and celebrate innovation and success in technology and technological developments related to the prevention of hospital infections.
- Ends -
For further information, please contact:
|David Chestnutt, Chief Executive||Tel: + 44 (0) 151 706 0626|
Seymour Pierce Limited
|Paul Davies, Corporate Finance||Tel: + 44 (0) 20 7107 8031|
|Henry Harrison-Topham / Stephanie Cuthbert||Tel: +44 (0) 20 7398 7718|
Notes to editors:
Proventec manages a complementary portfolio of integrated businesses that specialise in hygienic solutions and preventative coatings technologies. Headquartered in Liverpool, UK, the Company operates in global markets, pioneering developments within the healthcare, food manufacturing, hospitality industries, transportation, construction, and other sectors. Companies in Proventec's portfolio include:
|OspreyDeepClean||The world's leading provider of low pressure, chemical-free, specialist dry saturated steam cleaning technology.||34|
|Contico Manufacturing||Provider of general cleaning products and janitorial equipment and supplies.||45|
|Frank||Manufacturer and distributer of automated cleaning systems and products including portable high pressure washers, self-service vehicle wash stations and dry steamers.||22|
|CryoJet||Provider of a specialised, industrial cleaning service, utilising steam and proprietary dry-ice technology.||25|
|Magma Firestop||Develops a wide of range fire retardant coatings, for the treatment of building and thatching materials.||4|
|InnoShield Systems||Develops transparent coatings protecting against UV rays and corrosion.||1|
Proventec Healthcare provides innovative solutions for infection control and effective cleaning in the healthcare sector. The Company's specialist steam cleaning technology has been successfully proven in clinical trials with University College London Hospitals to rid all areas and combat the spread of micro-organisms, including 'superbugs' such as MRSA and Clostridium difficile. The Company has developed specialist, patented tooling, which has been designed to be used within hospitals on a daily basis and enable the user to clean difficult to reach areas including mattresses, bed frames and curtains without the use of antimicrobial chemicals that may contribute to microbial resistance.
The Company joined the AIM Market in June 2002 and was dual listed on Alternext in May 2008. For further information please visit www.proventecplc.comInformation non réglementée
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-15353-proventec_hcia_va.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|OSPREYFRANK||Euronext Paris||0.010 (c)||0.00%||0|